Comparable Treatment Efficacy of Switching to Dolutegravir/Lamivudine Versus Triple-Drug Antiretroviral Therapy in People with HIV After 2 Years of Follow-Up: The DUALING Prospective Nationwide Matched Cohort Study
Ferdinand W.N.M. Wit, Marc van der Valk, Bart Rijnders, Casper Rokx